| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1478520
[patent_doc_number] => 06451769
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'Compositions and methods for administering Borrelia DNA'
[patent_app_type] => B1
[patent_app_number] => 09/173053
[patent_app_country] => US
[patent_app_date] => 1998-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 53
[patent_no_of_words] => 19347
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451769.pdf
[firstpage_image] =>[orig_patent_app_number] => 09173053
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/173053 | Compositions and methods for administering Borrelia DNA | Oct 14, 1998 | Issued |
Array
(
[id] => 1599991
[patent_doc_number] => 06475779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-11-05
[patent_title] => 'Polymeric gene delivery'
[patent_app_type] => B2
[patent_app_number] => 09/173205
[patent_app_country] => US
[patent_app_date] => 1998-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7217
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/475/06475779.pdf
[firstpage_image] =>[orig_patent_app_number] => 09173205
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/173205 | Polymeric gene delivery | Oct 14, 1998 | Issued |
Array
(
[id] => 1012729
[patent_doc_number] => 06897200
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-24
[patent_title] => 'Oligonucleotide delivery systems for camptothecins'
[patent_app_type] => utility
[patent_app_number] => 09/807332
[patent_app_country] => US
[patent_app_date] => 1998-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 16021
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/897/06897200.pdf
[firstpage_image] =>[orig_patent_app_number] => 09807332
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/807332 | Oligonucleotide delivery systems for camptothecins | Oct 13, 1998 | Issued |
Array
(
[id] => 1189038
[patent_doc_number] => 06734171
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-11
[patent_title] => 'Methods for encapsulating nucleic acids in lipid bilayers'
[patent_app_type] => B1
[patent_app_number] => 09/169573
[patent_app_country] => US
[patent_app_date] => 1998-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 36
[patent_no_of_words] => 18291
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/734/06734171.pdf
[firstpage_image] =>[orig_patent_app_number] => 09169573
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/169573 | Methods for encapsulating nucleic acids in lipid bilayers | Oct 8, 1998 | Issued |
Array
(
[id] => 1566637
[patent_doc_number] => 06376471
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-23
[patent_title] => 'Gene delivery compositions and methods'
[patent_app_type] => B1
[patent_app_number] => 09/169739
[patent_app_country] => US
[patent_app_date] => 1998-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 7874
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/376/06376471.pdf
[firstpage_image] =>[orig_patent_app_number] => 09169739
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/169739 | Gene delivery compositions and methods | Oct 7, 1998 | Issued |
Array
(
[id] => 4342927
[patent_doc_number] => 06284533
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Plasmid-based vaccine for treating atherosclerosis'
[patent_app_type] => 1
[patent_app_number] => 9/171969
[patent_app_country] => US
[patent_app_date] => 1998-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15826
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284533.pdf
[firstpage_image] =>[orig_patent_app_number] => 171969
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/171969 | Plasmid-based vaccine for treating atherosclerosis | Oct 1, 1998 | Issued |
| 09/155667 | SPRAY-DRIED MICROPARTICLES AS THERAPEUTIC VEHICLES FOR USE IN GENE THERAPY | Sep 30, 1998 | Abandoned |
| 09/162101 | BIOLOGICALLY TOLERATED LOW MOLECULAR WEIGHT POLYETHYLENIMINES | Sep 27, 1998 | Abandoned |
Array
(
[id] => 4407440
[patent_doc_number] => 06172048
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-09
[patent_title] => 'Composition containing nucleic acids, preparation and uses'
[patent_app_type] => 1
[patent_app_number] => 9/160937
[patent_app_country] => US
[patent_app_date] => 1998-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4966
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/172/06172048.pdf
[firstpage_image] =>[orig_patent_app_number] => 160937
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/160937 | Composition containing nucleic acids, preparation and uses | Sep 24, 1998 | Issued |
Array
(
[id] => 1357524
[patent_doc_number] => 06573073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-06-03
[patent_title] => 'CFTR gene regulator'
[patent_app_type] => B2
[patent_app_number] => 09/142913
[patent_app_country] => US
[patent_app_date] => 1998-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 4379
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/573/06573073.pdf
[firstpage_image] =>[orig_patent_app_number] => 09142913
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/142913 | CFTR gene regulator | Sep 17, 1998 | Issued |
Array
(
[id] => 4405238
[patent_doc_number] => 06171863
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-09
[patent_title] => 'Materials and methods for intracellular delivery of biologically active molecules'
[patent_app_type] => 1
[patent_app_number] => 9/148953
[patent_app_country] => US
[patent_app_date] => 1998-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 2443
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/171/06171863.pdf
[firstpage_image] =>[orig_patent_app_number] => 148953
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/148953 | Materials and methods for intracellular delivery of biologically active molecules | Sep 7, 1998 | Issued |
| 09/145729 | METHOD OF TREATING PROSTATE CANCER WITH AN ADENOVIRUS TYPE 5 EXPRESSION VECTOR CONTAINING A TUMOR SUPPRESSOR GENE P16 AND A RSV PROMOTER | Sep 1, 1998 | Abandoned |
Array
(
[id] => 7964253
[patent_doc_number] => 06680301
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-20
[patent_title] => 'Transfer of molecules into the cytosol of cells'
[patent_app_type] => B2
[patent_app_number] => 09/144750
[patent_app_country] => US
[patent_app_date] => 1998-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 11768
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/680/06680301.pdf
[firstpage_image] =>[orig_patent_app_number] => 09144750
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/144750 | Transfer of molecules into the cytosol of cells | Aug 31, 1998 | Issued |
| 09/125227 | COMPOSITION FOR THE TRANSFECTION OF HIGHER EUCARYOTIC CELLS | Aug 13, 1998 | Abandoned |
| 09/133612 | COMPOSITIONS AND METHODS FOR INDUCING GENE EXPRESSION | Aug 12, 1998 | Abandoned |
Array
(
[id] => 4359993
[patent_doc_number] => 06255289
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-03
[patent_title] => 'Gene delivery by secretory gland expression'
[patent_app_type] => 1
[patent_app_number] => 9/130886
[patent_app_country] => US
[patent_app_date] => 1998-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13928
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/255/06255289.pdf
[firstpage_image] =>[orig_patent_app_number] => 130886
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/130886 | Gene delivery by secretory gland expression | Aug 6, 1998 | Issued |
| 08/981143 | ORAL DELIVERY OF GENE CONSTRUCTS | Aug 5, 1998 | Abandoned |
Array
(
[id] => 1520924
[patent_doc_number] => 06413941
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Polymer composition for delivering a nucleic acid or derivative thereof'
[patent_app_type] => B1
[patent_app_number] => 09/101254
[patent_app_country] => US
[patent_app_date] => 1998-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10621
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/413/06413941.pdf
[firstpage_image] =>[orig_patent_app_number] => 09101254
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/101254 | Polymer composition for delivering a nucleic acid or derivative thereof | Aug 2, 1998 | Issued |
Array
(
[id] => 4234150
[patent_doc_number] => 06143521
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-07
[patent_title] => 'Human bombesin receptor subtype-3sb'
[patent_app_type] => 1
[patent_app_number] => 9/120772
[patent_app_country] => US
[patent_app_date] => 1998-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11804
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/143/06143521.pdf
[firstpage_image] =>[orig_patent_app_number] => 120772
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/120772 | Human bombesin receptor subtype-3sb | Jul 21, 1998 | Issued |
Array
(
[id] => 4400020
[patent_doc_number] => 06270761
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'Delivery of nucleic acid'
[patent_app_type] => 1
[patent_app_number] => 9/000103
[patent_app_country] => US
[patent_app_date] => 1998-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 6258
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/270/06270761.pdf
[firstpage_image] =>[orig_patent_app_number] => 000103
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/000103 | Delivery of nucleic acid | Jun 28, 1998 | Issued |